ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-pxlviii.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-pxlviii.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-pxxi.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-pxxi.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p383.xmlImatinib Treatment of Lymphangiomatosis (Generalized Lymphatic Anomaly)2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p383.pdf2026-04-18Imatinib Treatment of Lymphangiomatosis (Generalized Lymphatic Anomaly)https://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p373.xmlNCCN Guidelines and Quality Cancer Care: Where Have We Come From, and Where Should We Be Going?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p373.pdf2026-04-18NCCN Guidelines and Quality Cancer Care: Where Have We Come From, and Where Should We Be Going?https://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p367.xmlLetting Nature Loose2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p367.pdf2026-04-18Letting Nature Loosehttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p450.xmlMelanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p450.pdf2026-04-18Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p407.xmlGuiding Lay Navigation in Geriatric Patients With Cancer Using a Distress Assessment Tool2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p407.pdf2026-04-18Guiding Lay Navigation in Geriatric Patients With Cancer Using a Distress Assessment Toolhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p421.xmlVariation in National Use of Long-Term ADT by Disease Aggressiveness Among Men With Unfavorable-Risk Prostate Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p421.pdf2026-04-18Variation in National Use of Long-Term ADT by Disease Aggressiveness Among Men With Unfavorable-Risk Prostate Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p429.xmlThe Cost of Initial Care for Medicare Patients With Advanced Ovarian Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p429.pdf2026-04-18The Cost of Initial Care for Medicare Patients With Advanced Ovarian Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p439.xmlPatterns of Palliative Care Consultation Among Elderly Patients With Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p439.pdf2026-04-18Patterns of Palliative Care Consultation Among Elderly Patients With Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p389.xmlNCCN Guidelines Insights: Multiple Myeloma, Version 3.20162026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p389.pdf2026-04-18NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016https://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p483.xmlTreatment Disparities Faced by Undocumented Workers From Low- and Middle-Income Countries in the United States With Hematologic Malignancies2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p483.pdf2026-04-18Treatment Disparities Faced by Undocumented Workers From Low- and Middle-Income Countries in the United States With Hematologic Malignancieshttps://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p475.xmlMolecular Profiling in Cutaneous Melanoma2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/14/4/article-p475.pdf2026-04-18Molecular Profiling in Cutaneous Melanoma